Show simple item record

dc.contributor.authorPardini, Barbara
dc.contributor.authorVerderio, Paolo
dc.contributor.authorPizzamiglio, Sara
dc.contributor.authorNici, Carmela
dc.contributor.authorMaiorana, Maria Valeria
dc.contributor.authorNaccarati, Alessio
dc.contributor.authorVodickova, Ludmila
dc.contributor.authorVymetalkova, Veronika
dc.contributor.authorVeneroni, Silvia
dc.contributor.authorDaidone, Maria Grazia
dc.contributor.authorRavagnani, Fernando
dc.contributor.authorBianchi, Tiziana
dc.contributor.authorBujanda Fernández de Pierola, Luis ORCID
dc.contributor.authorCarracedo, Angel
dc.contributor.authorCastells, Antoni
dc.contributor.authorRuiz Ponte, Clara
dc.contributor.authorMorreau, Hans
dc.contributor.authorHowarth, Kimberley
dc.contributor.authorJones, Angela
dc.contributor.authorCastellví-Bel, Sergi
dc.contributor.authorLi, Li
dc.contributor.authorTomlinson, Ian
dc.contributor.authorVan Wezel, Tom
dc.contributor.authorVodicka, Pavel
dc.contributor.authorRadice, Paolo
dc.contributor.authorPeterlongo, Paolo
dc.contributor.authorEPICOLON Consortium
dc.date.accessioned2014-03-31T15:17:58Z
dc.date.available2014-03-31T15:17:58Z
dc.date.issued2014-01
dc.identifier.citationPloS ONE 9(1) : (2014) // e85538es
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10810/11879
dc.description.abstractThe common 2652 6N del variant in the CASP8 promoter (rs3834129) has been described as a putative low-penetrance risk factor for different cancer types. In particular, some studies suggested that the deleted allele (del) was inversely associated with CRC risk while other analyses failed to confirm this. Hence, to better understand the role of this variant in the risk of developing CRC, we performed a multi-centric case-control study. In the study, the variant 2652 6N del was genotyped in a total of 6,733 CRC cases and 7,576 controls recruited by six different centers located in Spain, Italy, USA, England, Czech Republic and the Netherlands collaborating to the international consortium COGENT (COlorectal cancer GENeTics). Our analysis indicated that rs3834129 was not associated with CRC risk in the full data set. However, the del allele was under-represented in one set of cases with a family history of CRC (per allele model OR = 0.79, 95% CI = 0.69-0.90) suggesting this allele might be a protective factor versus familial CRC. Since this multi-centric case-control study was performed on a very large sample size, it provided robust clarification of the effect of rs3834129 on the risk of developing CRC in Caucasians.es
dc.description.sponsorshipThis work was supported by COST Action BM1206. Spanish cohort: The authors are sincerely grateful to all patients participating in this study who were recruited in 25 (EPICOLON 1) and 14 (EPICOLON 2) Spanish hospitals as part of the EPICOLON project. The authors are also indebted to the Genomics Unit of the Institut d'Investigacions Biome` diques August Pi i Sunyer for technical help. The work was carried out (in part) at the Esther Koplowitz Centre, Barcelona. SCB is supported by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070 to SCB). Networked Biomedical Research Centre for Hepatic and Digestive Diseases and Centro de Investigacion Biomedica en Red de Enfermedades Raras are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigacion Sanitaria/FEDER (08/0024, 08/1276, PS09/02368, 11/00219, 11/00681), Instituto de Salud Carlos III (Accion Transversal de Cancer), Xunta de Galicia (07PXIB9101209PR), Ministerio de Ciencia e Innovacion (SAF2010-19273), Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona), FundacioOlga Torres (SCB and CRP), FP7 CHIBCHA Consortium (SCB and A. Carracedo). Italian cohort: The authors thank all individuals who agreed to participate in the study. The authors also thank the personnel of Tissue Bank of Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto dei Tumori for sample collection and all pathologists for their contribution and collaboration. American cohort: Kentucky Colon Cancer Genetic Epidemiology Study is supported by National Institutes of Health grant R01CA136726 to LL. English cohort: Core funding to the Wellcome Trust Centre for Human Genetics was provided by the Wellcome Trust (090532/Z/09/Z). Czech cohort: Grant agency of the Czech Republic (GACR) [CZ: GACR: GA P304/10/1286 and P304/12/1585] and by Prvouk-P27/LF1/1 from Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic as a recipient). Dutch cohort: Dutch Cancer Society, grant KWF-UL-2010-4656.es
dc.language.isoenges
dc.publisherPublic Library Sciencees
dc.relationinfo:eu-repo/grantAgreement/MICINN/SAF2010-19273
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectsusceptibility locies
dc.subjectgenees
dc.subjectmetaanalysises
dc.subjectprognosises
dc.subjectpromoteres
dc.titleAssociation between CASP8-652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Studyes
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2014 Pardini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es
dc.relation.publisherversionhttp://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085538es
dc.identifier.doi10.1371/journal.pone.0085538
dc.departamentoesMedicinaes_ES
dc.departamentoeuMedikuntzaes_ES
dc.subject.categoriaAGRICULTURAL AND BIOLOGICAL SCIENCES
dc.subject.categoriaMEDICINE
dc.subject.categoriaBIOCHEMISTRY AND MOLECULAR BIOLOGY


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record